These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 15706675)

  • 21. Early withdrawal in a double-blind randomized clinical trial with olanzapine and risperidone performed in adolescents with first psychosis.
    van Nimwegen L; de Haan L
    Psychopathology; 2006; 39(3):158. PubMed ID: 16531692
    [No Abstract]   [Full Text] [Related]  

  • 22. [Study questions the benefit of the treatment. Aggressive Alzheimer patient -- a (not a) case for atypical neuroleptics?].
    Kurz A
    MMW Fortschr Med; 2006 Nov; 148(47):16. PubMed ID: 17168181
    [No Abstract]   [Full Text] [Related]  

  • 23. Risperidone treatment in elderly patients with dementia: relative risk of cerebrovascular events versus other antipsychotics.
    Finkel S; Kozma C; Long S; Greenspan A; Mahmoud R; Baser O; Engelhart L
    Int Psychogeriatr; 2005 Dec; 17(4):617-29. PubMed ID: 16202186
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risperidone and dementia-related aggression: new indication. A last resort, no better than haloperidol.
    Prescrire Int; 2009 Dec; 18(104):248. PubMed ID: 20025088
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of risperidone versus olanzapine in patients with schizophrenia previously on chronic conventional antipsychotic therapy: a switch study.
    Wang X; Savage R; Borisov A; Rosenberg J; Woolwine B; Tucker M; May R; Feldman J; Nemeroff CB; Miller AH
    J Psychiatr Res; 2006 Oct; 40(7):669-76. PubMed ID: 16762371
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tardive dyskinesia in older patients.
    Jeste DV
    J Clin Psychiatry; 2000; 61 Suppl 4():27-32. PubMed ID: 10739328
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risperidone questioned as dementia first-line treatment.
    Saxe T
    Geriatrics; 2004 Feb; 59(2):11; author reply 11-2. PubMed ID: 14989589
    [No Abstract]   [Full Text] [Related]  

  • 28. [General practice study with atypical neuroleptics. Differences in tolerance].
    MMW Fortschr Med; 2002 May; Suppl 2():86. PubMed ID: 12070866
    [No Abstract]   [Full Text] [Related]  

  • 29. New antipsychotic drugs produce better outcomes.
    Healthc Benchmarks; 1997 Oct; 4(10):142-4. PubMed ID: 10173374
    [No Abstract]   [Full Text] [Related]  

  • 30. [Increased risk of stroke during the use of olanzapine or risperidone in patients with dementia].
    van Marum RJ; Jansen PA
    Ned Tijdschr Geneeskd; 2005 Jan; 149(4):165-7. PubMed ID: 15702733
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Olanzapine for psychotic and behavioral disturbances in Alzheimer disease.
    Schatz RA
    Ann Pharmacother; 2003 Sep; 37(9):1321-4. PubMed ID: 12921516
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Atypical antipsychotics and risk of cerebrovascular accidents.
    Herrmann N; Mamdani M; Lanctôt KL
    Am J Psychiatry; 2004 Jun; 161(6):1113-5. PubMed ID: 15169702
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Atypical antipsychotics for the treatment of dementia-related behaviors: an update.
    Daiello LA
    Med Health R I; 2007 Jun; 90(6):191-4. PubMed ID: 17633594
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Orally disintegrating olanzapine for the treatment of psychotic and behavioral disturbances associated with dementia.
    Reeves RR; Torres RA
    South Med J; 2003 Jul; 96(7):699-701. PubMed ID: 12940325
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A pilot study of risperidone, olanzapine, and haloperidol in psychotic youth: a double-blind, randomized, 8-week trial.
    Sikich L; Hamer RM; Bashford RA; Sheitman BB; Lieberman JA
    Neuropsychopharmacology; 2004 Jan; 29(1):133-45. PubMed ID: 14583740
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Risperidone and cerebrovascular adverse effects in elderly patients with dementia].
    Formiga F; Fort I; Pérez-Castejón JM; Ruiz D; Duaso E; Riu S
    Rev Clin Esp; 2006 Sep; 206(8):411-2; author reply 412-3. PubMed ID: 16863635
    [No Abstract]   [Full Text] [Related]  

  • 37. Sleep-related eating disorder induced by risperidone.
    Lu ML; Shen WW
    J Clin Psychiatry; 2004 Feb; 65(2):273-4. PubMed ID: 15003084
    [No Abstract]   [Full Text] [Related]  

  • 38. Risperidone for the treatment of behavioral and psychological symptoms of dementia.
    Tune LE
    J Clin Psychiatry; 2001; 62 Suppl 21():29-32. PubMed ID: 11584986
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacology of antipsychotics in the elderly: a focus on atypicals.
    Finkel S
    J Am Geriatr Soc; 2004 Dec; 52(12 Suppl):S258-65. PubMed ID: 15541166
    [No Abstract]   [Full Text] [Related]  

  • 40. Hyperprolactinemia in an adolescent with psychotic disorder on risperidone.
    Jummani R; Coffey BJ
    J Child Adolesc Psychopharmacol; 2009 Dec; 19(6):791-4. PubMed ID: 20035598
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.